Focalin XR Approval History
- FDA approved: Yes (First approved May 26th, 2005)
- Brand name: Focalin XR
- Generic name: dexmethylphenidate
- Company: Novartis Pharmaceuticals Corporation
- Treatment for: ADHD
Focalin XR (dexmethylphenidate) is a once-daily extended-release form of Focalin indicated for the treatment of Attention-Deficit/Hyperactivity Disorder (ADHD) in adults, adolescents and children.
FDA Approval History for Focalin XR
|Nov 12, 2008||FDA Approves 30-Minute Onset of Action for Focalin XR|
|May 26, 2005||Focalin XR Novartis Pharmaceuticals Corporation - Treatment for Attention-Deficit/Hyperactivity Disorder (ADHD)|
Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.